Inmune Bio Files 8-K: Regulation FD & Exhibits
Ticker: INMB · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, filing, financials
Related Tickers: INMB
TL;DR
INMB filed an 8-K for Reg FD and exhibits, standard stuff.
AI Summary
On April 3, 2025, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns a Regulation FD Disclosure and the filing of Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Inmune Bio is providing required disclosures and submitting financial documents to the SEC, which is standard practice for public companies.
Risk Assessment
Risk Level: low — The filing is a routine disclosure and does not appear to contain any new material negative or positive information.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- April 3, 2025 (date) — Date of earliest event reported
- 225 NE Mizner Blvd. , Suite 640 , Boca Raton , Florida 33432 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Inmune Bio, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and the filing of Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is April 3, 2025.
What is the principal executive office address for Inmune Bio, Inc.?
The principal executive office address is 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
What is the company's state of incorporation?
The company's state of incorporation is Nevada.
What is the registrant's telephone number?
The registrant's telephone number is (858) 964-3720.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding Inmune Bio, Inc. (INMB).